OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Robert Roskoski
Pharmacological Research (2024) Vol. 200, pp. 107059-107059
Open Access | Times Cited: 146
Robert Roskoski
Pharmacological Research (2024) Vol. 200, pp. 107059-107059
Open Access | Times Cited: 146
Showing 1-25 of 146 citing articles:
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
Christopher M. Marshall, John G. Federice, Chloe N. Bell, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11622-11655
Closed Access | Times Cited: 110
Christopher M. Marshall, John G. Federice, Chloe N. Bell, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11622-11655
Closed Access | Times Cited: 110
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
Hydrolysis, Ligand Exchange, and Redox Properties of Vanadium Compounds: Implications of Solution Transformation on Biological, Therapeutic, and Environmental Applications
Rupam Dinda, Eugenio Garribba, Daniele Sanna, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 3
Rupam Dinda, Eugenio Garribba, Daniele Sanna, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 3
Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions
Hongyao Li, Xiang Wen, Yueting Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Hongyao Li, Xiang Wen, Yueting Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Chemical proteomics approaches for protein post-translational modification studies
Nan Zhang, Jinghua Wu, Qingfei Zheng
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2024) Vol. 1872, Iss. 4, pp. 141017-141017
Open Access | Times Cited: 9
Nan Zhang, Jinghua Wu, Qingfei Zheng
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2024) Vol. 1872, Iss. 4, pp. 141017-141017
Open Access | Times Cited: 9
Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas
Robert Roskoski
Pharmacological Research (2024) Vol. 203, pp. 107181-107181
Open Access | Times Cited: 8
Robert Roskoski
Pharmacological Research (2024) Vol. 203, pp. 107181-107181
Open Access | Times Cited: 8
Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials
José Pinto-Fraga, Celia García-Chico, Simone Lista, et al.
Pharmacological Research (2025) Vol. 212, pp. 107528-107528
Open Access | Times Cited: 1
José Pinto-Fraga, Celia García-Chico, Simone Lista, et al.
Pharmacological Research (2025) Vol. 212, pp. 107528-107528
Open Access | Times Cited: 1
A novel pyridine-2-one AMPK inhibitor: discovery, mechanism, and in vivo evaluation in a hypoxic pulmonary arterial hypertension rat model
Wenhua Tan, Yu Wang, Mengqi Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117266-117266
Closed Access | Times Cited: 1
Wenhua Tan, Yu Wang, Mengqi Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117266-117266
Closed Access | Times Cited: 1
Colorectal Cancer Spectrum: From Subtypes and Epidemiology to Oncotherapies
Nidhi Agrawal, Sanjay Kumar Lanjhiyana, Meenakshi Jaiswal, et al.
Gastroenterology & Endoscopy (2025)
Open Access | Times Cited: 1
Nidhi Agrawal, Sanjay Kumar Lanjhiyana, Meenakshi Jaiswal, et al.
Gastroenterology & Endoscopy (2025)
Open Access | Times Cited: 1
Modulating the phosphorylation status of target proteins through bifunctional molecules
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access | Times Cited: 1
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access | Times Cited: 1
Investigation of the anticancer activity of modified 4-hydroxyquinolone analogues: in vitro and in silico studies
Yousra Ouafa Bouone, Abdeslem Bouzina, Abdelhak Djemel, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3704-3720
Open Access | Times Cited: 1
Yousra Ouafa Bouone, Abdeslem Bouzina, Abdelhak Djemel, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3704-3720
Open Access | Times Cited: 1
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies
Yasmin M. Syam, Somaia S. Abd El‐Karim, Heba T. Abdel‐Mohsen
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 7
Yasmin M. Syam, Somaia S. Abd El‐Karim, Heba T. Abdel‐Mohsen
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 7
A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target
Ajaya Kumar Rout, Budheswar Dehury, Satya Narayan Parida, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132030-132030
Closed Access | Times Cited: 6
Ajaya Kumar Rout, Budheswar Dehury, Satya Narayan Parida, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132030-132030
Closed Access | Times Cited: 6
A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures
Noah B. Herrington, Yan Chak Li, David Stein, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 7, pp. e1012302-e1012302
Open Access | Times Cited: 6
Noah B. Herrington, Yan Chak Li, David Stein, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 7, pp. e1012302-e1012302
Open Access | Times Cited: 6
Targeted and cytotoxic inhibitors used in the treatment of breast cancer
Robert Roskoski
Pharmacological Research (2024), pp. 107534-107534
Open Access | Times Cited: 5
Robert Roskoski
Pharmacological Research (2024), pp. 107534-107534
Open Access | Times Cited: 5
Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Modern Management Approaches for Alopecia Areata
Eduard Т. Ambarchian, Vladislav V. Ivanchikov, Anastasia D. Kuzminova, et al.
Вопросы современной педиатрии (2025) Vol. 23, Iss. 6, pp. 516-522
Open Access
Eduard Т. Ambarchian, Vladislav V. Ivanchikov, Anastasia D. Kuzminova, et al.
Вопросы современной педиатрии (2025) Vol. 23, Iss. 6, pp. 516-522
Open Access
Combating chemoresistance: Current approaches & nanocarrier mediated targeted delivery
Siuli Shaw, Subrata K. Pore, D.-M. Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189261-189261
Closed Access
Siuli Shaw, Subrata K. Pore, D.-M. Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189261-189261
Closed Access
Application of a macrocyclization strategy in kinase inhibitor development
Kun Xing, Shujun Li, Jing Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Kun Xing, Shujun Li, Jing Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Preclinical evidence that fibroblast growth factor receptor pathway inhibition by BGJ398 enhances small cell lung cancer response to chemotherapy
Yingying Shen, Yan Jiang, Junyao Wu, et al.
Anti-Cancer Drugs (2025)
Closed Access
Yingying Shen, Yan Jiang, Junyao Wu, et al.
Anti-Cancer Drugs (2025)
Closed Access
The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 124-124
Open Access
Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 124-124
Open Access
Sorafenib as Adjuvant Therapy Post–Liver Transplant: A Single-center Experience
Hala Hassanain, Ashton A. Connor, Elizabeth W. Brombosz, et al.
Transplantation Direct (2025) Vol. 11, Iss. 2, pp. e1746-e1746
Open Access
Hala Hassanain, Ashton A. Connor, Elizabeth W. Brombosz, et al.
Transplantation Direct (2025) Vol. 11, Iss. 2, pp. e1746-e1746
Open Access
Insulin receptor tyrosine kinase substrate in health and disease (Review)
Xueyan Zhang, Zhewen Zhang
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Closed Access
Xueyan Zhang, Zhewen Zhang
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Closed Access
